UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 725

Sortiert nach

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

Annals of oncology, 2018-04, Vol.29 (4), p.945-952

2018

Volltextzugriff (PDF)

Development of a nomogram for predicting survival in microsatellite stable patients with resected colorectal cancer

Annals of oncology, 2018-10, Vol.29, p.viii199-viii199

2018

Volltextzugriff (PDF)

Predictive biomarkers for non-muscle invasive bladder cancer patients undergoing BCG treatment

European urology open science (Online), 2020-07, Vol.19, p.e1361

2020

Volltextzugriff (PDF)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis

Cancer management and research, 2020-01, Vol.12, p.1621-1630

2020

Volltextzugriff (PDF)

An EGFR -Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report

OncoTargets and therapy, 2020-02, Vol.13, p.1845-1849

2020

Volltextzugriff (PDF)

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric cancer

Annals of oncology, 2019-10, Vol.30, p.v300-v301

2019

Volltextzugriff (PDF)

779P - HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric cancer

Annals of oncology, 2019-10, Vol.30, p.v300-v301

2019

Volltextzugriff (PDF)

P76.38 Afatinib as a Potential Therapeutic Option for Non-small Cell Lung Cancer Patients with EGFR G724S

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S603-S603

2021

Volltextzugriff (PDF)

P35.11 Molecular Profiling Can Distinguish Multiple Lung Primary Tumors From Intrapulmonary Metastases

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S424-S424

2021

Volltextzugriff (PDF)

P76.28 Phase II Study of the Efficacy of the EGFR Inhibitor Mefatinib in Patients with Advanced EGFR-mutant NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S598-S599

2021

Volltextzugriff (PDF)

141P - A comprehensive pan-cancer study of FGFR aberrations in Chinese cancer patients

Annals of oncology, 2019-10, Vol.30, p.v44-v44

2019

Volltextzugriff (PDF)

A comprehensive pan-cancer study of FGFR aberrations in Chinese cancer patients

Annals of oncology, 2019-10, Vol.30, p.v44

2019

Volltextzugriff (PDF)

P1.01-20 The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S363-S363

2019

Volltextzugriff (PDF)

P76.20 The Predictive Values of Non-Resistant Nncommon EGFR Mutations in Advanced Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S594-S595

2021

Volltextzugriff (PDF)

Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

Annals of oncology, 2019-10, Vol.30, p.v602-v603

2019

Volltextzugriff (PDF)

1479O - Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

Annals of oncology, 2019-10, Vol.30, p.v602-v603

2019

Volltextzugriff (PDF)

P082 DNA Methylation: A More Sensitive Marker for Treatment Monitoring?

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.S1077-S1078

2018

Volltextzugriff (PDF)

P1.01-91 Clinical Outcomes of Various Resistance Mechanisms of Osimertinib in Chinese Advanced Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S396-S396

2019

Volltextzugriff (PDF)

P1.01-18 Integrated Genomic and DNA Methylation Analyses of Non-Small Cell Lung Cancer Patients with Brain Metastases

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S362-S362

2019

Volltextzugriff (PDF)

MA08.09 Clinical Management of Lung Adenocarcinoma Patients With HER2 V659E Mutation

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S163-S163

2021

Volltextzugriff (PDF)

P1.09-31 Clinicopathological Features and Genomic Profiling of Pulmonary Blastoma with High-Grade Fetal Adenocarcinoma Component

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S508-S508

2019

Volltextzugriff (PDF)

P2.09-11 Genomic Profiling of Pulmonary Lymphoepithelioma-Like Carcinoma (PLELC)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S772-S773

2019

Volltextzugriff (PDF)

P1.03-34 Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S524-S525

2018

Volltextzugriff (PDF)

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S408-S409

2018

Volltextzugriff (PDF)

P1.01-037 Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1908-S1908

2017

Volltextzugriff (PDF)

1 – 25 von 725

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(685)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(595)
Life Sciences & Biomedicine
(272)
Physical Sciences
(243)
Technology
(155)
Humans
(144)
Chemistry
(126)
Physics
(98)
Animals
(78)
Pharmacology & Pharmacy
(66)
Male
(65)
Exact Sciences And Technology
(64)
Materials Science
(63)
Biological And Medical Sciences
(62)
Female
(57)
Engineering
(56)
Chemistry, Multidisciplinary
(55)
Computer Science
(49)
Materials Science, Multidisciplinary
(45)
Medical Sciences
(43)
Chemistry, Organic
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

Development of a nomogram for predicting survival in microsatellite stable patients with resected colorectal cancer

Predictive biomarkers for non-muscle invasive bladder cancer patients undergoing BCG treatment

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis

An EGFR -Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric cancer

779P - HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric cancer

P76.38 Afatinib as a Potential Therapeutic Option for Non-small Cell Lung Cancer Patients with EGFR G724S

P35.11 Molecular Profiling Can Distinguish Multiple Lung Primary Tumors From Intrapulmonary Metastases

P76.28 Phase II Study of the Efficacy of the EGFR Inhibitor Mefatinib in Patients with Advanced EGFR-mutant NSCLC

141P - A comprehensive pan-cancer study of FGFR aberrations in Chinese cancer patients

A comprehensive pan-cancer study of FGFR aberrations in Chinese cancer patients

P1.01-20 The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

P76.20 The Predictive Values of Non-Resistant Nncommon EGFR Mutations in Advanced Non-Small Cell Lung Cancer Patients

Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

1479O - Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

P082 DNA Methylation: A More Sensitive Marker for Treatment Monitoring?

P1.01-91 Clinical Outcomes of Various Resistance Mechanisms of Osimertinib in Chinese Advanced Non-Small Cell Lung Cancer Patients

P1.01-18 Integrated Genomic and DNA Methylation Analyses of Non-Small Cell Lung Cancer Patients with Brain Metastases

MA08.09 Clinical Management of Lung Adenocarcinoma Patients With HER2 V659E Mutation

P1.09-31 Clinicopathological Features and Genomic Profiling of Pulmonary Blastoma with High-Grade Fetal Adenocarcinoma Component

P2.09-11 Genomic Profiling of Pulmonary Lymphoepithelioma-Like Carcinoma (PLELC)

P1.03-34 Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

P1.01-037 Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival

Suchergebnisse filtern